BioNTech is set to request approval across the globe to use its COVID-19 vaccine in children as young as five over the next few weeks and preparations for a launch are on track, the biotech firm’s two top executives told Der Spiegel.
BioNTech to seek global approval to use its COVID-19 vaccine in 5-11 year olds: report
